Reports for BAXTER CORPORATION
Company Name
BAXTER CORPORATION
Totals |
||
Shortage reports |
197 |
|
| Actual shortage: | 7 (4%) | |
| Anticipated shortage: | 1 (1%) | |
| Avoided shortage: | 3 (2%) | |
| Resolved: | 186 (94%) | |
Discontinuation Reports |
26 |
|
| To be discontinued: | 0 (0%) | |
| Discontinued: | 26 (100%) | |
| Reversed: | 0 (0%) | |
Late reports |
11 (5%) |
|
Overdue reports |
0 (0%) |
|
Shortage reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|
Discontinuation reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| ACID CONCENTRATE 2125 | 89.99G 8.11G 3.21G 7.74G 3.35G 268.24G | SOLUTION | Discontinued | 2017-04-19 | 2017-12-22 | 7240 |
| 0.9% SODIUM CHLORIDE INJECTION, USP | 900MG | SOLUTION | Discontinued | 2020-07-23 | 2020-07-23 | 120952 |
| 0.9% SODIUM CHLORIDE INJECTION, USP | 900MG | SOLUTION | Discontinued | 2020-07-23 | 2020-07-23 | 120955 |
| ACID CONCENTRATE D12304 | 90G 10.8G 1.61G 7.48G 263G | SOLUTION | Discontinued | 2017-04-19 | 2017-12-22 | 7264 |
| ACID CONCENTRATE 2163 | 90G 10.8G 2.14G 6.24G 10.06G 275G | SOLUTION | Discontinued | 2017-04-19 | 2017-12-22 | 7249 |
| CLINIMIX E | 90MG 210MG 20MG 261MG 58.5MG 24MG 205MG 20G 310MG 310MG 290MG 290MG 1.04G 1.04G 520MG 240MG 230MG 220MG 210MG | SOLUTION | Discontinued | 2020-06-22 | 2021-03-26 | 118604 |